Drug-related problems in preterm neonatal patients on parental nutrition

This research was carried out in the Neonatology ward of the Angela Loayza Obstetric Hospital in Ollague in a study period of 15 months from January 1, 2019 to March 30, 2020. Objective: To evaluate problems related to medications in preterm neonatal patients, treated with parenteral nutrition through pharmacotherapeutic follow-up to optimize drug and nutritional therapy for patients. Methodology: The present investigation has a quantitative approach of documentary bibliographic modality, not experimental with a retrospective descriptive cross-sectional design. Results: 280 medical records were analyzed, finding 213 Drug-Related Problems (DRP) in 172 premature newborns, of which it was identified that the most affected with DRP corresponded to patients with 36 weeks of gestational age, male and female. neonates with weights between 2001- 2500 gr. The prevalence of 213, the one with the highest incidence present in Parenteral Nutrition is the PRM of Effectiveness with 37% of Effectiveness, followed by 33% of Necessity and 30% of Safety. Likewise, it was observed that PRMs were found in the group of concentrated electrolytes that are part of parenteral nutrition. Finally, it was determined that the inadequate dose was the main cause of the DRPs, followed by the prescription errors in the therapeutic and nutritional treatments of the patients. Conclusion: The Pharmacotherapeutic Follow-up determined that more than 50% of patients who were fed parenterally presented some type of DRP.